Clinical Trial Update: Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates a Phase 1/2 study evaluating the combination of abemaciclib and elacestrant in participants with ER+/HER-2- breast cancer a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Orserdu (Elacestrant)
• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Stemline Therapeutics, Inc. | Conditions: Breast Neoplasms, Brain Neoplasms | Phase 1, Phase 2 | Status: RECRUITING